Review on Ketoprofen (Anti-Inflammatory Drug)

Bhupendra Kumar; Vandana Sahani; Shivanand Patil

doi:10.55544/jrasb.3.6.6

Authors

Bhupendra Kumar Research Scholar, Department of Pharmacy, Shree Dev Bhoomi Institute of Education Science and Technology (SDBIT), Dehradun, INDIA.
Mrs. Vandana Sahani Associate Professor, Department of Pharmacy, Shree Dev Bhoomi Institute of Education Science and Technology (SDBIT), Dehradun, INDIA.
Dr. Shivanand Patil Professor, Department of Pharmacy, Shree Dev Bhoomi Institute of Education Science and Technology (SDBIT), Dehradun, INDIA.

DOI:

https://doi.org/10.55544/jrasb.3.6.6

Keywords:

Ketoprofen, Dysmenorrhea, Osteoarthritis, Cyclooxygenase

Abstract

Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) widely utilized for its analgesic, anti-inflammatory, and antipyretic properties. This review article examines ketoprofen's pharmacological profile, efficacy, and therapeutic applications, particularly in the management of acute and chronic pain, including dysmenorrhea, osteoarthritis, and rheumatoid arthritis. Ketoprofen exerts its effect by inhibiting the cyclooxygenase (COX) enzymes, COX-1 and COX- 2, reducing the synthesis of prostaglandins responsible for pain and inflammation. Various formulations of ketoprofen are available, including oral tablets, topical gels, suppositories, and injectables, each tailored to specific clinical needs and patient preferences. Recent advancements in topical and extended-release formulations have improved patient adherence and minimized gastrointestinal side effects traditionally associated with NSAIDs. However, ketoprofen remains contraindicated in patients with certain cardiovascular, renal, and gastrointestinal conditions, underscoring the need for careful patient selection and dosage adjustment. This review highlights ketoprofen's clinical efficacy, safety profile, and evolving therapeutic applications, providing insight into its role within the broader scope of pain management strategies.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Adachi, H., et al. "Physical characteristics, pharmacological properties and clinical efficacy of the ketoprofen patch: a new patch formulation." European Review for Medical & Pharmacological Sciences 15.7 (2011).

BIJLSMA JW. Patient benefit-risk in arthritis a rheumatologist's perspective. Rheumatology (Ox ford) 2010; 49(Suppl 2): ii11- 17.

HAROUTIUNIAN S, DRENNAN DA, LIPMAN AG. Topical NSAID therapy for musculoskeletal pain. Pain Med 2010; 11:535-549.

MASON L. MOORE RA, EDWARDS JE, DERRY S, MCQUAY HJ. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskeletal Disord 2004; 5: 28.

MASON L. MOORE RA, EDWARDS JE, DERRY S, MCQUAY HJ. Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract 2004;5:10.

Kuczynska, Joanna, and Barbara Nieradko-Iwanicka. "New uses of ketoprofen–a review of studies from 2015 to 2021." Current Issues in Pharmacy and Medical Sciences 35.1 (2022): 16-20.

Chawla G, Ranjan C, Kumar J, Siddiqui AA. Chemical modifications of ketoprofen (NSAID) in search of better lead compounds: A Review of literature from 2004-2016. Antiinflamm Antiallergy Agents Med Chem. 2017;15(3):154-77

Kuczyńska J, Nieradko-Iwanicka B. Future prospects of ketoprofen in improving the safety of the gastric mucosa. Biomed Pharmacother. 2021;139:111608.

Patrignani P, Patrono C. Cyclooxygenase inhibitors: From pharmacology to clinical read-outs. Biochim Biophys Acta. 2015; 1851(4):422-32.

Miles, S. Ketoprofen, Marshall University, Joan C. School of Medicine, Huntington, USA, 2007.

Marie, L, Ulf, A, Karin, L, Berit B. Bioequivalence determination of topical ketoprofen using a dermatopharmacokinetic approach and excised skin penetration, Int J Pharm 284: 23– 30, 2004.

Üner, M, Gönüllü, Ü, Yener, G, Altınkurt, T. A New Approach for Preparing a Controlled Release Ketoprofen Tablets by Using Beeswax, II Farmaco, 60: 27-31, 2005.

Sökmen, N, Uysal, S, Ayhan, F, Özyazıcı, M, Ayhan, H. Photopolymerized Poly(Ethylene Glycol) Diacrylate Hydrogels for Controlled Release of Ketoprofen, Hacet J B Chem 37(4): 337 343, 2009.

Kheradmandnia, S, Vasheghani-Farahani, E, Nosrati, M, Atyabi, F. Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax, Nanomed-Nanotechnol 6: 753–759, 2010+

Lu, WL, Zhang, Q, Zheng, L, Wang, H, Lı, RY, Zhang, LF, Shen, WB, Tu, XD. Antipyretic, analgesic and anti-inflammatory activities of ketoprofen β-cyclodextrin ınclusion complexes in animals, Biol Pharm Bull 27(10): 1515-1520, 2004.

Jamali, F, Brocks, DR. Clinical pharmacokinetics of ketoprofen and its enantiomers, Clin Pharmacokinet 19(3): 197–217, 1990.

Blanco, M, Gonzalez, JM, Torras, E, Valverde, I. Enantiomeric purity determination of ketoprofen by capillary electrophoresis: development and validation of the method, Anal Bioanal Chem 375: 157–163, 2003.

Lastra, CA, Nieto, A, Motilva, V, Martin, MJ, Herrerías, JM, Cabre, F, Mauleon, D. Intestinal toxicity of ketoprofen- trometamol vs its enantiomers in rat. Role of oxidative stress, Inflamm Res 49: 627–632, 2000.

Vergote, GJ, Vervaet, C, Van Driessche, I, Hoste, S, Smedt, S, Demeester, J, Jain, RA, Ruddy, S, Remon, JP. In vivo evaluation of matrix pellets containing nanocrystalline ketoprofen, Int J Pharm 240: 79-84, 2002.

Sheng, JJ, Kasim, NA, Chandrasekharan, R, Amidon, GL. Solubilization and Dissolution of Insoluble Weak Acid, Ketoprofen: Effect of pH Combined Surfactant, Eur J Pharm Sci 29: 306 314, 2006.

Löbenberg, R, Amidon, GL. Modern bioavailabil ity, bioequivalence and biopharmaceutics clas sification system. New scientific approaches to international regulatory standards, Eur J Pharm Biopharm 50: 3-12, 2000

Maestrelli, F, Zerrouk, N, Cirri, M, Mennini, N, Mura, P. Microspheres for colonic delivery of ketoprofen- hydroxypropyl-β-cyclodextrin complex, Eur J Pharm Sci 34:1- 11, 2008.

Zakeri-Milani, P, Barzegar-Jalali, M, Azimi, M, Valizadeh, H. Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability, Eur J Pharm Biopharm 73: 102–106, 2009

Ali, W, Williams, Stochiometrically AC, Rawlinson, CF. governed molecular interactions in drug: Poloxamer solid dispersions, Int J Pharm 391: 162–168, 2010.

Pickla, KE, Magnesa, C, Bodenlenza, M, Piebera, TR, Sinner, FM. Rapid online-SPE-MS/MS method for ketoprofen determination in dermal interstitial fluid samples from rats obtained by microdialysis or open-flow microperfusion, J Chromatogr B 850(1): 432-439, 2007.

bd-el-Bary, A, Geneidy, A, Osman, A, Shalaby, S, Morshan, A, Solid state stability of ketoprofen in the presence of different excipients, Pharmazie. 54(3): 202-206, 1999.

European Pharmacopoeia 6.0, p.2218-2219.

Clarke’s Isolation and Identification of Drugs, London: The Pharmaceutical Press, p.697-698, 1986.

British Pharmacopeia, The Stationery Office, London p.922,1464, 2005.

Bonazzi, D, Audrisano, V, Gatti, R, Cavrini, V. Analysis of pharmaceutical creams: a useful approach based on solid- phase extraction (SPE) and UV spectrophotometry, J Pharm Biomed Anal 13: 1321–1329, 1995

Zhuang, Y, Song, H. Sensitive determination of ketoprofen using flow injection with chemiluminescence detection, J Pharm Biomed Anal 44: 824-828, 2007. USP XXX-NF XXV, 2009, pp. 1090, 2439

Iuliani, P, Carlucci, G, Marrone, A. Investigation of the HPLC response of NSAIDs by fractional experimental design and multivariate regression analysis. Response optimization and new retention parameters, J Pharm Biomed Anal 51: 46–55, 2010.

Donato, MG, Baeyens, W, Van Den Bossche, W, Sandra, P. The determination of non-steroidal antiinflammatory drugs in pharmaceuticals by capillary zone electrophoresis and micellar

electrokinetic capillary chromatography, J Pharm Biomed Anal 12: 21–26, 1994.

Ozlu, C, Basan, H, Satana, E, Ertas, N, Goger, NG. Quantitative determination of ketoprofen in gels and ampules by using flow-injection UV spectrophotometry and HPLC, J Pharm Biomed Anal 39: 606–611, 2005

Dvorak, J, Hajkova, R, Matysova, L, Novakova, L, Koupparis, MA, Solich, P. Simultaneous HPLC determination of ketoprofen and its degradation products in the presence of preservatives in pharmaceuticals, J Pharm Biomed Anal, 36: 625 629, 2004.

Kemper, MS, Magnuson, EJ, Lowry, SR, McCarthy, WJ, Aksornkoae, N, Watts, DC, Johnson, JR, Shukla, AJ. Use of FT- NIR Transmission Spectroscopy for the Quantitative Analysis of an Active Ingredient in a Translucent Pharmaceutical Topical Gel Formulation, AAPS Pharm Sci 23(3): 81-85, 2001.

Daharia, A., Jaiswal, V. K., Royal, K. P., Sharma, H., Joginath, A. K., Kumar, R., & Saha, P. (2022). A Comparative review on ginger and garlic with their pharmacological Action. Asian Journal of Pharmaceutical Research and Development, 10(3), 65-69.

Dubey, A., Yadav, P., Verma, P., & Kumar, R. (2022). Investigation of proapoptotic potential of ipomoea carnea leaf extract on breast cancer cell line. Journal of Drug Delivery and Therapeutics, 12(1), 51-55.

Bind, A., Das, S., Singh, V. D., Kumar, R., Chourasia, A., & Saha, P. (2020). Natural bioactives for the potential management of gastric ulceration. Turkish Journal of Physiotherapy and Rehabilitation, 32(3), 221-226.

Saha, P., Nyarko, R. O., Lokare, P., Kahwa, I., Boateng, P. O., & Asum, C. (2022). Effect of Covid-19 in Management of Lung Cancer Disease: A Review. Asian Journal of Pharmaceutical Research and Development, 10(3), 58-64.

Saha, P. (2020). Evolution of tolbutamide in the treatment of diabetes mellitus. Diabetes, 2(10).

Saha, P., Kumar, R., Nyarko, R. O., Kahwa, I., & Owusu, P. (2021). Herbal Secondary Metabolite For Gastro-Protective Ulcer Activity With Api Structures.

Nyarko, R. O., Prakash, A., Kumar, N., Saha, P., & Kumar, R. (2021). Tuberculosis a globalized disease. Asian Journal of Pharmaceutical Research and Development, 9(1), 198-201.

Sahana, S. (2020). Purabi saha, Roshan kumar, Pradipta das, Indranil Chatterjee, Prasit Roy, Sk Abdur Rahamat. A Review of the 2019 Corona virus (COVID-19) World Journal of Pharmacy and Pharmaceutical science, 9(9), 2367-2381.

Sahana, S., Kumar, R., Nag, S., Paul, R., Chatterjee, I., & Guha, N. (2020). A Review On Alzheimer Disease And Future Prospects.

Kumar, R., Saha, P., Sarkar, S., Rawat, N., & Prakash, A. (2021). A Review On Novel Drug Delivery System. IJRAR-International Journal of Research and Analytical Reviews (IJRAR), 8(1), 183-199

Nyarko, R. O., Kumar, R., Sharma, S., Chourasia, A., Roy, A., & Saha, P. (2022). Antibacterial Activity of Herbal Plant-Tinospora Cordifolia And Catharnthus Roseus. Ghattas

Jalon, EG, Josa, M, Campanero, MA, Santoyo, S, Ygartua, P. Determination by high-performance liquid chromatography of ketoprofen in vitro in rat skin permaeation samples, J Chromatogr A 870: 143-149, 2000.

Blanco, M, Alcala, M, Bautista, M. Pharmaceutical gel analysis by NIR spectroscopy Determination of the active principle and low concentration of preservatives, Eur J Pharm Sci 3 3: 409– 414, 2008.

Zholt K, Iryna, H, Yaroslav, B. Spectrophotometric Determination of Ketoprofen and Its Application in Pharmaceutical Analysis. Acta Poloniae Pharm Drug Res, 66(1): 3-9, 2009.

Aboul-Enein, HY, Dal, AG, Tuncel, M. A validated method development for ketoprofen by a flow injection analysis with UV-detection and its application to pharmaceutical formulations, II Farmaco 58: 419–422, 2003.

Mohammad, A, Sharma, S, Bhawani, SA. Identification of Ketoprofen in Drug Formulation and Spiked Urine Samples by Micellar Thin Layer Chromatography and its Quantitative Estimation by High Performance Liquid Chromatography, Int J Pharm Tech Res 2(1): 89-96, 2010

Sancin, P, Caputo, O, Cavallari, C, Passerini, N, Rodriguez, L, Cinib, M, Fini, A. Effects of ultrasound-assisted compaction on Ketoprofen/ Eudragit S100 Mixtures, Eur J Pharm Sci 7: 207 213, 1999.

Choı, S, Kim, S, Ryoo, JJ, Park, JY, Lee, KP. FT Raman and FT-IR

Spectra of the Non-steroidal Anti-inflammatory Drug Ketoprofen Included in Cyclodextrins, Anal Sci 17: 85-88, 2001.

Abdel-Hamid, ME, Novotny, L, Hamza, H. Determination of Diclofenac Sodium, Flufenamic Acid, Indomethacin and Ketoprofen by LC APCI-MS, J Pharm Biomed Anal 24: 587 – 594, 2001.

Moore, RA, Tramer, MR, Carroll, D, Wiffen, PJ, McQuay, HJ. Quantitative systematic review of topically, applied non- steroidal anti-inflammatory drugs, Br Med J 316: 333-338, 1998.

Sunshine, A, Olson, NZ, Zighelboim, I, Castro, A, Caracas, NY. Ketoprofen, acetaminophen plus oxycodone, and acetaminophen in the relief of postoperative pain, Clin Pharm Th 54: 546–555, 1993.

Li, KL, Vogel, R, Jeffcoat, MK, Alfano, MC, Smith, MA, Collins, JG, Offenbacher, S. The effect of ketoprofen creams on periodontal disease in rhesus monkeys, J Periodontal Res 31: 525, 1996.

Moretti MD, Gavini E, Peana AT. In vitro release and anti- inflammatory activity of topical formulations of ketoprofen, Boll Chim Farm 139 (2): 67-72, 2000.

Lawrence, M.J.; Rees, G.D.; Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 45, 89-121 (2000).

Tadros, T.; Izquierdo, P.; Esquena, J.; Solans, C. Forma tion and stability of nanoemulsions. Adv. Colloid Interface Sci. 108(109), 303-318 (2004)

Williams, A.C., dan Barry, B.W. Penetration Enhancers. Advanced Drug Delivery Reviews. 2004; 56: 603-618.

Okyar, A., Ozsoy, Y., dan Gungor. Novel Formulation Approaches for Dermal and Transdermal Delivery of Non- Steroidal Anti Inflamatory